Timber Creek Capital Management LLC

Position in AZN — Astrazeneca PLC

CIK 1510848 BOSTON, MA

Position in AZN

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$6,152,220

New position

Shares Held

32,445

first reported quarter

Ownership

0.002%

of shares outstanding

% of Portfolio

1.28%

of 13F equity value

Holder Rank

#366

of 1,462 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Timber Creek Capital Management LLC holds $29,474,538 across 5 Drug Manufacturers - General names. AZN ranks #2 (20.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	12,882	$15,451,058
2	AZN	Astrazeneca PLC This page	32,445	$6,152,220
3	NVS	Novartis AG	35,388	$5,546,007
4	AMGN	Amgen Inc	4,730	$1,712,827
5	PFE	Pfizer Inc	25,433	$612,426

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,152,220	32,445	—	Shares	Sole	2026-08-10
No filing history on record for this holder in this stock.